Search results

Selected filters:

News
Non-Practising Entities

Article type

Topic

Sector

Regions

Year

147 results found for your search

Sort options
12 October 2015

Inside the global patent market 2015: an infographic

In issue 72 of IAM, we revealed the results from our Global Benchmarking Survey, looking at developments in the global patent market. Based on responses from hundreds of senior corporate, private practice and NPE operators, the findings showed that…

24 September 2015

Mark Cuban is not a patent hypocrite, he is merely a sinner in the process of repenting

You have got to admire Mark Cuban’s chutzpah, if nothing else. As a self-proclaimed enemy of patent trolls, a vocal advocate for fundamental change to the US patent system and the funder of the EFF’s Mark Cuban Chair to Eliminate Stupid Patents,…

11 September 2015

“Odds of success are just too small now” for licensors, says outgoing WiLAN CEO Jim Skippen

Back in June WiLAN announced that its CEO Jim Skippen would be stepping down after nine years at the helm. When he took the top spot at the Canadian NPE, it had a market capitalisation of less than C$30 million. Today, it stands at well over C$300…

11 September 2015

Chances of patent reform this year look slim as Congress returns from summer break

Mark Cuban, entrepreneur, NBA team owner and star of the TV show Shark Tank (the US equivalent of the BBC’s Dragons’ Den) was on Capitol Hill this week in part to help bring a little stardust to the push for patent reform. Cuban is the backer of the…

21 July 2015

Acacia is a bellwether NPE and well-placed to ride out current market uncertainties

Acacia Research has in many ways been a trailblazer for the NPE market. It initially pursued a large-scale approach to licensing through a volume-based strategy before shifting to a focus on marquee portfolios. It has expanded its horizons to take…

17 July 2015

The Kyle Bass pharma patent IPR strategy looks to be a lot more sophisticated and long-term than many think

Last week we published an interview with Kyle Bass, the hedge fund investor who together with Erich Spangenberg, has petitioned to challenge a series of pharmaceutical patents through the inter partes review (IPR) process at the Patent Trial and…

10 July 2015

Big pharma is terrified of what I am doing, but I am bringing greater clarity to the market, says Bass

This time a few months ago no-one inside the world of IP would have given Hayman Capital founder and manager Kyle Bass a second thought, unless they were one of his investors. Now, though, his name is on everyone’s lips. Since teaming up with Erich…

09 July 2015

From Congress to the USPTO, there's an assumption that only patent plaintiffs abuse the system; but it's wrong

In the ongoing debate around patent reform in the US there are two distinct narratives at play. The first is well known to anyone that has even only occasionally followed the progress of the proposed legislation.   It is the claim championed by…

19 June 2015

We will offer equitable deals to any company and litigate regardless of nationality, says IP Bridge CEO

Earlier this month, IAM reported on two significant patent portfolio acquisitions made by Japanese 'sovereign patent fund' IP Bridge. At the time, I wrote that the fund's progress "has largely been shrouded in mystery" and that "many…

18 June 2015

The car industry’s patent evolution leaves many questions to be answered

One of the key questions for auto manufacturers and the large tech players like Apple and Google that are looking to enter the car space, is whether the changes the industry is going through now represent a fundamental shift to a completely new…

18 June 2015

US patent leadership may be over and the IP market is changing, but opportunities abound

Unsurprisingly, one of the key themes at this year’s IPBC in San Francisco was that the US market is in a state of serious flux. There was no consensus on whether the pendulum has swung too far against the interests of patent owners – your views on…

17 June 2015

A new approach to the reform debate; China's IP future; the European tide; and much more at IPBC Global Day 3

IPBC Global in San Francisco is now finished, but only after another compelling day of sessions, networking and discussion. Here, IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – pick out a few of the highlights: …

16 June 2015

Patent values about to climb, heroic inventors, the US's patent failure, hope for SMEs, and much more at the IPBC

The first full day of the IPBC Global in San Francisco is now done and dusted. Here, IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – pick out a few of the highlights from the sessions and from the conversations…

15 June 2015

Networking, reform, Japanese influx, NPE worries and much more as IPBC Global kicks off

The opening reception for this year’s IPBC Global took place on Sunday evening at the Palace Hotel in San Francisco. IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – are covering the event and below are a few…

09 June 2015

As the Americans look set to abdicate global patent leadership Europe has an exciting opportunity

A perfect patent storm is brewing for Europe. The creation of the unitary patent system – with one patent covering an economically advanced  territory of around 600 million people and a single court system, with the potentially wide availability of…